CBIO had a pop in Feb, but its been a long and painful downtrend for this stock for the longest time.

There is some big action here at the moment:

>SOUTH SAN FRANCISCO, Calif., March 28, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that the Korean Ministry of Food and Drug Safety (MFDS) approved the Investigational New Drug Application (IND) for CB 2679d/ISU304. Hemophilia is a serious bleeding disorder that results in spontaneous bleeding episodes as well as substantially prolonged bleeding times upon injury.

Anybody trading this?

View Reddit by StockJock-eView Source